Phc Holdings Corp. · TSE:6523
Phc — Investor Presentation (November 2024)
38 slides from Phc's investor presentation, November 2024
Slide 1: Introduction to PHC Group
Introduction to PHC Group PHC Holdings Corporation
Slide 2: Contents
Contents 1 PHC Group Overview P.03 4 Business Domains P.12 Diabetes Management P.13 P.16 2 Healthcare Solutions P.18 Our History P.20 P.06 P.23 Diagnostics & Life Sciences P.25 ©PHC Holdings Corporation 2024 P.27 3 Mission／Vision／Values P.08 5 Sustainability P.32 2
Slide 3: PHC Group Overview
1 PHC Group Overview ©PHC Holdings Corporation 2024 Overview History Mission／Vision／Values Diabetes Management Healthcare Solutions Diagnostics & Life Sciences Sustainability 3
Slide 4: PHC Group Overview
PHC Group Overview Company PHC Holdings Corporation Name 15F DAI-ICHI LIFE HIBIYA FIRST Business Address/ 1-13-2 Yurakucho, Chiyoda-ku, Head Office Tokyo 100-8403, Japan Founded 1969 (Founded as Matsushita Kotobuki Electronics Co., Ltd.) President, Representative Director and CEO Representative Kyok
Slide 5: PHC Group Highlights
PHC Group Highlights PHC Group is a global network of healthcare companies dedicated to improving health through digital and precision technology. Since our founding in Japan in 1969, we have been driving better health through solutions in diagnostics, life sciences, diabetes management, and health
Slide 6: Our History
2 Our History ©PHC Holdings Corporation 2024 Overview History Mission／Vision／Values Diabetes Management Healthcare Solutions Diagnostics & Life Sciences Sustainability 6
Slide 7: PHC Group History
PHC Group History PHC Holdings Corporation listed on the First Section Wemex of the Tokyo Stock Corporation*2 Acquisition of anatomical Exchange*1 begins operations pathology business from Thermo Fisher Scientific, Acquisition of diabetes Inc. to establish Epredia care business from Bayer Holdings L
Slide 8: Mission／Vision／Values
3 Mission／Vision／Values ©PHC Holdings Corporation 2024 Overview History Mission／Vision／Values Diabetes Management Healthcare Solutions Diagnostics & Life Sciences Sustainability 8
Slide 9: Mission／Vision／Values
Mission／Vision／Values We contribute to the health of society through our diligent efforts to create healthcare solutions that have a positive impact and improve the lives of people. Be a leader in precision technology that powers the future of healthcare. Curiosity ©PHC Holdings Corporation 2024 Cou
Slide 10: PHC Group Business Domains
PHC Group Business Domains Diabetes Management Healthcare Solutions Diagnostics & Life Sciences • Blood Glucose • Clinical Testing • Healthcare • Supports research • Anatomical Pathology • Research/Medical • Diagnostic Reagents and Instruments ©PHC Holdings Corporation 2024 Monitoring Systems IT Sol
Slide 11: Global Network
Global Network Our global business includes 88 subsidiaries, with sales in more than 125 countries and region. JAPAN • Manufacturing Sites (Including R&D Sites) ／8 • Sales Sites ／114 ©PHC Holdings Corporation 2024 • Testing Laboratories ／33 PHC Corporation PHC Corporation R&D/manufacturing sites R&D
Slide 12: Business Domains
4 Business Domains ©PHC Holdings Corporation 2024 Overview History Mission／Vision／Values Diabetes Management Healthcare Solutions Diagnostics & Life Sciences Sustainability 12
Slide 13: Diabetes Management Overview
Overview Ascensia Diabetes Care is a global leader in diabetes technology. We have been entirely dedicated to improving the health and lives of people with diabetes for over 80 years. Our Strengths Target Customers Serving people with diabetes in more than 100 People with 1 countries and regions Dia
Slide 14: Main Products and Services
Main Products and Services Our blood glucose monitoring systems are highly accurate and easy-to-use, and widely accepted by patients around the world. Ascensia offer solutions to effectively manage diabetes while leveraging monitored data through the integration of digital technology. Blood Glucose
Slide 15: Diabetes Management Global Network
Diabetes Management Global Network Manufacturing sites in Indonesia and Japan, and operations in more than 30 countries and regions. …Countries/regions involved in Diabetes Management business (not including distributors’ offices) ©PHC Holdings Corporation 2024 • Ascensia Diabetes Care Holdings AG(S
Slide 16: Overview (LSI Medience)
Overview Since the founding of its predecessor Medical Science Corporation in 1975, the business that is now LSI Medience has contributed to the prevention, early detection, and treatment of diseases through clinical testing. Our Strengths Target Customers Diverse testing portfolio with more than 4,
Slide 17: Main Products and Services
Main Products and Services LSI Medience provides services in clinical testing through laboratory analysis, including cancer diagnostics, genetic testing, and sports doping testing. Clinical Testing Doping Tests Through its Laboratory Automation System responds to advanced Supports global anti-doping
Slide 18: Overview (Wemex)
Overview Wemex is a healthcare solution provider contributing to the digital transformation of healthcare. The business has a long history of providing cutting-edge healthcare IT for clinics and pharmacies in Japan, starting with launching Japan's first medical-receipt computer system in 1972. Our S
Slide 19: Main Products and Services
Main Products and Services Wemex offers electronic medical record and electronic medication history systems interfaced with online eligibility verification and e-prescriptions, as well as API integration with services provided by other companies. Healthcare Operation Support Systems Preventive Medic
Slide 20: Overview (Mediford)
Overview Mediford was established in 2023, integrating the clinical trial business previously under LSI Medience Corporation and the non- clinical testing business formerly under LSIM Safety Science Institute Corporation. Our Strengths Target Customers Unique drug development technologies (PDX・PDC,
Slide 21: Main Products and Services
Main Products and Services Mediford offers services that support a wide range of research and development, from the exploratory phase of drug development to clinical testing, using reliable testing and analytical capabilities accumulated through extensive experience in contract research. Non-clinica
Slide 22: Healthcare Solutions Network in Japan
Healthcare Solutions Network in Japan R&D, manufacturing, laboratory, and sales sites across Japan Headquarters Headquarters Headquarters （Minato-ku, Tokyo） （Shibuya-ku, Tokyo） （Itabashi-ku, Tokyo） R&D or • Itabashi/Tokyo • Saitama • Ibaraki Manufacturing • Nagano • Kumamoto Sites • Fukuoka Sales Si
Slide 23: Overview (Epredia)
Overview Epredia is a global leader in anatomical pathology, working to improve patient outcomes by providing a comprehensive range of solutions for precision cancer diagnostics. Every second of every day, 48 Epredia products are used in the battle against cancer. Our Strengths Target Customers Rese
Slide 24: Main Products and Services
Main Products and Services From instruments to microscope slides and staining reagents, Epredia's diagnostic solutions help to improve workflow efficiency from specimen collection to analysis. Together they enable safer, quicker, and more accurate diagnoses of cancer. Histology Staining Labeling and
Slide 25: Overview (Biomedical business)
Overview Since the launch of its business as Sanyo Electric Co., Ltd. in 1966, the Biomedical business has supported medical practice and life science research with its industry-leading technologies and commitment to quality through manufacturing excellence. Our Strengths Target Customers Industry-l
Slide 26: Main Products and Services
Main Products and Services Through three segments of solutions in life science, pharmacy, and food catering, we create new values in life science research and medical practice. Pharmaceutical Refrigerators with History of Innovation Ultra-Low Temperature Freezers CO2 Incubators （Japan） Freezer / Pha
Slide 27: Overview (PHC IVD)
Overview The diagnostics businesses of PHC Corporation and LSI Medience were integrated under PHC IVD in 2023. The resulting restructured PHC IVD provides highly accurate, reliable, and high-value-added medical devices and in-vitro diagnostics. Our Strengths Target Customers Medical Device Pharmaceu
Slide 28: Main Products and Services
Main Products and Services PHC IVD contributes to real-time testing in medical practices through its highly accurate diagnostic reagents, developed from the industry's first latex technology, and its compact POCT (point of care testing) devices. Diagnostic Reagents Diagnostic Instruments History of
Slide 29: Main Products and Services
Main Products and Services We collaborate with partners to contribute to the detection and treatment of diseases such as diabetes and asthma. Blood Glucose POC System Blood Glucose Monitoring Lancing Devices/ Self-Monitoring System （For HbA1c/lipid/CRP testing） System for Hospitals/Clinics Lancets S
Slide 30: Diagnostics & Life Sciences Global Network
Diagnostics & Life Sciences Global Network Manufacturing facilities in Europe, the U.S. and Asia. Sales offices in 14 countries for Epredia and eight countries for PHCbi. Epredia Holdings Ltd. Headquarters (U.S.) …Countries/regions involved in Diagnostics & Life Science business (not including distr
Slide 31: Diagnostics & Life Sciences Network in Japan
Diagnostics & Life Sciences Network in Japan … Prefectures where Diagnostics & Life Science • Tokyo Sales Sites business-related sales offices are located • Osaka (not including distributors’ offices) • Fukuoka …Headquarters of Group Companies …Manufacturing Sites Sales Sites • Hokkaido • Aichi …R&D
Slide 32: Sustainability
5 Sustainability ©PHC Holdings Corporation 2024 Overview History Mission／Vision／Values Diabetes Management Healthcare Solutions Diagnostics & Life Sciences Sustainability 32
Slide 33: Sustainability
Sustainability Environment Social Governance ©PHC Holdings Corporation 2024 Overview History Mission／Vision／Values Diabetes Management Healthcare Solutions Life Sciences and Diagnostics Sustainability 33
Slide 34: Environment
Sustainability Environment PHC Group strives to maintain a sustainable environment at our manufacturing bases around the world. In Japan and the outsides, we have obtained ISO 14001 certification and are engaged in activities to conserve the environment; for example, efficient energy use and environ
Slide 35: Social
Sustainability Social As we create new value through healthcare innovation, we recognize the magnitude of our potential impact on people’s health as a healthcare company. First and foremost, it is of the utmost importance to fulfill our responsibility for product safety and quality. We contribute to
Slide 36: Governance
Sustainability Governance Strong corporate governance is essential to ensure transparency, fairness, and timeliness in management, and to achieve sustainable corporate growth and improvement in corporate value. One concept related to these goals is the establishment of a system for management execut
Slide 37: Participation in sustainability initiatives / Evaluation
Sustainability Participation in sustainability initiatives / Evaluation Selected as a constituent of the MSCI Japan Earned the Commitment Badge in EcoVadis' Disclosed our environmental Equity ESG Select Leaders Index*1 Sustainability Assessment*2 information through CDP*3 Ranked AA in the latest MSC
Slide 38: Published in November 2024
PHc GROUP Published in November 2024